UnitedHealth Group Stock Rises Despite Decline in Operating Earnings
UnitedHealth Group's stock price has risen following its latest earnings report. The company reported $400.3 billion in revenue for 2025, a $28.7 billion increase from 2024. However, operating earnings fell by $10.2 billion to $22.1 billion.
The company attributed the decline in operating earnings to higher medical costs and regulatory pressures. Despite this, UnitedHealth Group's stock price has risen due to its large scale and diversified business model. The company serves about 83 million people across its businesses, making it one of the largest health care platforms in the US.
Optum, a key division within UnitedHealth Group, remained central to the company's earnings profile in 2025. Optum links care delivery, pharmacy benefits, and analytics, providing a significant source of revenue for the company. The division's ability to expand with enough margin support will be closely watched by investors.